Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in Dermatomyositis

Small-fiber neuropathy (SFN) is suggested to be involved in the pathogenesis of some types of autoimmune connective tissue diseases. SFN with a reduction in epidermal nerve fibers might affect sensory fibers and cause neuropathic symptoms, such as pruritus and pain, which are common in both dermatom...

Full description

Bibliographic Details
Main Authors: Lai-San Wong, Chih-Hung Lee, Yu-Ta Yen
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/16/9030
_version_ 1797409843283230720
author Lai-San Wong
Chih-Hung Lee
Yu-Ta Yen
author_facet Lai-San Wong
Chih-Hung Lee
Yu-Ta Yen
author_sort Lai-San Wong
collection DOAJ
description Small-fiber neuropathy (SFN) is suggested to be involved in the pathogenesis of some types of autoimmune connective tissue diseases. SFN with a reduction in epidermal nerve fibers might affect sensory fibers and cause neuropathic symptoms, such as pruritus and pain, which are common in both dermatomyositis (DM) and cutaneous lupus erythematosus (CLE). Nerve growth factor (NGF) has been recognized as important in nociception by regulating epidermal nerve fiber density and sensitizing the peripheral nervous system. The present study aimed to investigate whether SFN was associated with the cutaneous manifestations of DM and CLE. We also investigated the relationship between SFN and axon guidance molecules, such as NGF, amphiregulin (AREG), and semaphorin (Sema3A) in DM and CLE. To explore the molecular signaling, interleukin (IL)-18 and IL-31, which have been implicated in the cutaneous manifestation and neuropathic symptoms in DM, were examined in keratinocytes. Our results revealed that intraepidermal nerve fiber density (IENFD) was unchanged in patients with DM, but significantly reduced in IENFD in patients with CLE compared with healthy control. Increased epidermal expression of NGF and decreased expression of Sema3A were demonstrated in patients with DM. Furthermore, IL-18 and IL-31 both induced the production of NGF from keratinocytes. Taken together, IL-18 and IL-31 mediated epidermal NGF expression might contribute to the cutaneous neuropathic symptoms in DM, while SFN might be important for CLE.
first_indexed 2024-03-09T04:21:22Z
format Article
id doaj.art-dade68fe55e84ab0a91ec2d89435af2d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T04:21:22Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-dade68fe55e84ab0a91ec2d89435af2d2023-12-03T13:48:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-08-012316903010.3390/ijms23169030Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in DermatomyositisLai-San Wong0Chih-Hung Lee1Yu-Ta Yen2Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, TaiwanDepartment of Dermatology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, TaiwanDepartment of Dermatology, Fooyin University Hospital, Pingtung 928, TaiwanSmall-fiber neuropathy (SFN) is suggested to be involved in the pathogenesis of some types of autoimmune connective tissue diseases. SFN with a reduction in epidermal nerve fibers might affect sensory fibers and cause neuropathic symptoms, such as pruritus and pain, which are common in both dermatomyositis (DM) and cutaneous lupus erythematosus (CLE). Nerve growth factor (NGF) has been recognized as important in nociception by regulating epidermal nerve fiber density and sensitizing the peripheral nervous system. The present study aimed to investigate whether SFN was associated with the cutaneous manifestations of DM and CLE. We also investigated the relationship between SFN and axon guidance molecules, such as NGF, amphiregulin (AREG), and semaphorin (Sema3A) in DM and CLE. To explore the molecular signaling, interleukin (IL)-18 and IL-31, which have been implicated in the cutaneous manifestation and neuropathic symptoms in DM, were examined in keratinocytes. Our results revealed that intraepidermal nerve fiber density (IENFD) was unchanged in patients with DM, but significantly reduced in IENFD in patients with CLE compared with healthy control. Increased epidermal expression of NGF and decreased expression of Sema3A were demonstrated in patients with DM. Furthermore, IL-18 and IL-31 both induced the production of NGF from keratinocytes. Taken together, IL-18 and IL-31 mediated epidermal NGF expression might contribute to the cutaneous neuropathic symptoms in DM, while SFN might be important for CLE.https://www.mdpi.com/1422-0067/23/16/9030cutaneous lupus erythematosusdermatomyositisnerve growth factorsmall-fiber neuropathy
spellingShingle Lai-San Wong
Chih-Hung Lee
Yu-Ta Yen
Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in Dermatomyositis
International Journal of Molecular Sciences
cutaneous lupus erythematosus
dermatomyositis
nerve growth factor
small-fiber neuropathy
title Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in Dermatomyositis
title_full Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in Dermatomyositis
title_fullStr Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in Dermatomyositis
title_full_unstemmed Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in Dermatomyositis
title_short Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in Dermatomyositis
title_sort increased epidermal nerve growth factor without small fiber neuropathy in dermatomyositis
topic cutaneous lupus erythematosus
dermatomyositis
nerve growth factor
small-fiber neuropathy
url https://www.mdpi.com/1422-0067/23/16/9030
work_keys_str_mv AT laisanwong increasedepidermalnervegrowthfactorwithoutsmallfiberneuropathyindermatomyositis
AT chihhunglee increasedepidermalnervegrowthfactorwithoutsmallfiberneuropathyindermatomyositis
AT yutayen increasedepidermalnervegrowthfactorwithoutsmallfiberneuropathyindermatomyositis